2½Ã°£ ÇãÇ÷ ÈÄ Àç°ü·ù ½ÃÁ¡¿¡ µû¸¥ ÈòÁãÀÇ Ç÷û ¹× ÀåµýÁö±ÙÀÇ Ä£¿°Áõ¼º »çÀÌÅäÄ«ÀÎ ¹× Ç׿°Áõ¼º »çÀÌÅäÄ«ÀÎÀÇ º¯È­
The Changes of Pro- and Anti-inflammatory Cytokines in Both Serum and Gastrocnemius Muscle of Mice after 2-hour Postischemic Reperfusion Injury

´ëÇÑüÁúÀηùÇÐȸÁö 2014³â 27±Ç 2È£ p.101 ~ p.111

±è½Å¿µ(Kim Shin-Young) - ÇѾç´ëÇб³ Àǰú´ëÇÐ ÇØºÎ.¼¼Æ÷»ý¹°Çб³½Ç

Abstract

º» ¿¬±¸´Â ÇãÇ÷ ÈÄ Àç°ü·ù ½ÃÁ¡¿¡ µû¶ó Ç÷û°ú »À´ë±ÙÀ°¿¡¼­ ³ªÅ¸³ª´Â Ä£¿°Áõ¼º ¹× Ç׿°Áõ¼º »çÀÌÅäÄ«ÀÎ(pro- and anti-inflammatory cytokine)ÀÇ º¯È­ ¾ç»óÀ» ºñ±³ ºÐ¼®ÇÏ¿© »À´ë±ÙÀ°ÀÇ ÇãÇ÷ ÈÄ Àç°ü·ù ½ÃÁ¡¿¡ µû¶ó ³ªÅ¸³ª´Â ¿°Áõ¼º ¹ÝÀÀÀÇ º¯È­¿Í À̸¦ ´ëÇ¥ÇÒ ¼ö Àִ ǥÁöÀÎÀÚ¸¦ È®ÀÎÇÏ´Â µ¥ ¸ñÀûÀÌ ÀÖ´Ù.
½ÇÇ赿¹°Àº 12ÁÖ·É ICR°è ¼öÄÆ »ýÁ㸦 »ç¿ëÇÏ¿© ´ëÁ¶±º°ú ÇãÇ÷ ÈÄ Àç°ü·ù ½Ã°£¿¡ µû¶ó Àç°ü·ù 0, 0.5, 1, 2, 4, 8, 16, 24½Ã°£±ºÀ¸·Î ºÐ·ùÇÏ¿´°í, ÇãÇ÷ óġ´Â ¿Þ¿Â¾ûµ¢µ¿¸Æ(left common iliac artery)À» 2½Ã°£ µ¿¾È Ç÷°üÁý°Ô·Î Â÷´ÜÇÏ¿´´Ù. Àç°ü·ù ½Ã°£°æ°ú¿¡ ¸ÂÃß¾î ½ÇÇ赿¹°À» ¸¶Ãë½ÃŲ ÈÄ ½ÉÀåÀÇ ¿À¸¥ ½É¹æ¿¡¼­ äÃëÇÑ Ç÷¾×ÀÇ Ç÷û°ú ÀåµýÁö±Ù Á¶Á÷¾×¿¡¼­ Ä£¿°Áõ¼º »çÀÌÅäÄ«ÀÎ (Eotaxin, IFN¥ã, IL-1¥á, IL-1¥â, IL-2, IL-3, IL-5, IL-6, MCP-1, MDC, MIP-1¥á, RANTES, TARC, TCA-3)°ú Ç׿°Áõ¼º »çÀÌÅäÄ«ÀÎ(IL-4, IL-10)ÀÇ º¯È­¸¦ È®ÀÎÇϱâ À§ÇÏ¿© ELISA ºÐ¼®À» ½ÃÇàÇÏ¿´´Ù.
¿¬±¸°á°ú ÇãÇ÷ ÈÄ Àç°ü·ù ½ÃÁ¡¿¡ µû¸¥ Ä£¿°Áõ¼º »çÀÌÅäÄ«ÀÎÀÇ ¹ßÇöÀº »À´ë±ÙÀ° ³» Àç°ü·ù 0½Ã°£±º¿¡¼­, Ç÷û¿¡¼­´Â ´ëÁ¶±º°ú Àç°ü·ù 0, 1, 2, 4, 8, 16½Ã°£±º¿¡¼­ »çÀÌÅäÄ«ÀÎµé »çÀÌÀÇ ¹ßÇö¾çÀÇ Â÷À̰¡ À¯ÀÇÇÑ °ÍÀ¸·Î °üÂûµÇ¾ú°í(p?.05), Ç׿°Áõ¼º »çÀÌÅäÄ«ÀÎÀÇ ¹ßÇöÀº Ç÷û ³» Àç°ü·ù 4½Ã°£±º¿¡¼­ »çÀÌÅäÄ«ÀÎµé »çÀÌÀÇ ¹ßÇö¾çÀÇ Â÷À̰¡ À¯ÀÇÇÑ °ÍÀ¸·Î °üÂûµÇ¾ú´Ù(p?.05). ¶ÇÇÑ ´ëÁ¶±º°ú ºñ±³ÇÏ¿© À¯ÀÇÇÑ Â÷À̸¦ º¸ÀÌ´Â Àç°ü·ù ½Ã°£Àº Ä£¿°Áõ¼º »çÀÌÅäÄ«Àο¡¼­´Â Ç÷û ³» Àç°ü·ù 2, 4, 16½Ã°£±ºÀ̾ú°í, Ç׿°Áõ¼º »çÀÌÅäÄ«Àο¡¼­´Â Ç÷û ³» Àç°ü·ù 4½Ã°£±ºÀ̾ú´Ù(p?.05).
º» ¿¬±¸¸¦ Åä´ë·Î ÇãÇ÷ ÈÄ »çÀÌÅäÄ«ÀεéÀÇ º¯È­ ¾ç»óÀº Àç°ü·ù ½ÃÁ¡¿¡ µû¶ó »À´ë±ÙÀ°º¸´Ù´Â Ç÷û¿¡¼­ ¹ßÇö¾çÀÇ Â÷À̰¡ À¯ÀÇÇÏ°Ô ³ªÅ¸³µÀ¸¸ç, ƯÈ÷ Ç÷û¿¡¼­ Àç°ü·ù 4½Ã°£±º¿¡ °üÂûµÇ´Â IL-6¿Í Àç°ü·ù 16½Ã°£±º¿¡ °üÂûµÇ´Â MCP-1Àº ´Ù¸¥ »çÀÌÅäÄ«Àκ¸´Ù À¯ÀÇÇÏ°Ô ³ôÀº ³óµµ¸¦ º¸ÀÓ¿¡ µû¶ó Ä£¿°Áõ¼º »çÀÌÅäÄ«ÀÎÀ» ´ëÇ¥Çϴ ǥÁöÀÎÀÚ°¡ µÉ ¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÈ´Ù.
This study aimed to investigate the inflammatory changes and their main indicators according to the time-period of postischemic reperfusion injury confirmed by analyzing changes of both pro-inflammatory and anti-inflammatory cytokines in the skeletal muscle and serum.
By using 12-week-old male ICR strain mice were grouped into sham control and 8 different time-periods of reperfusion groups (0, 0.5, 1, 2, 4, 8, 16, 24 hours). Left common iliac artery of each mice in the reperfusion group was devascularized by a vascular clamp for 2 hours. Once anesthesia was applied to the experimental animals, blood serum was obtained from right heart atrium on the difference time-period of reperfusion (0-, 0.5-, 1-, 2-, 4-, 8-hour, respectively). Then, tissue fluid was collected in calf muscles (gastrocnemius muscle) after the mice were sacrificed by cervical dislocation. By using these serum and tissue fluids, enzyme-linked immunosorbent assay (ELISA) was used to analyze both pro-inflammatory cytokines (Eotaxin, IFN¥ã, IL-1¥á, IL-1¥â, IL-2, IL-3, IL-5, IL- 6, MCP-1, MDC, MIP-1¥á, RANTES, TARC, TCA-3) and anti-inflammatory cytokines (IL-4, IL-10). Consequently, there were significant differences of pro-inflammatory cytokines levels in the skeletal muscle of 0- hour reperfusion group (p?.05) and those in the serum of 0-, 1-, 2-, 4-, 8-, 16-hour reperfusion groups (p?.05). In the serum of 4-hour reperfusion group, the presence of anti-iflammatory cytokines was significant from other groups (p?.05). By the comparison with the control group, furthermore, pro-inflammatory cytokines in the serum of 2-, 4-, 16-hour reperfusion group and anti-inflammatory cytokines in the serum of 4-hour reperfusion group were considerably different (p?.05).
To sum up, changes of cytokine levels according to the time-period of reperfusion were considerably different in the serum rather than the tissue fluids from the skeletal muscle. In particular, IL-6 and MCP-1 in the serum showed higher density in 4- and 16-hour reperfusion groups so that they could be considered as the main indicator of pro-inflammatory cytokines.

Ű¿öµå

ÇãÇ÷, Àç°ü·ù, Ä£¿°Áõ¼º »çÀÌÅäÄ«ÀÎ, Ç׿°Áõ¼º »çÀÌÅäÄ«ÀÎ
Ischemia, Reperfusion, Pro-inflammatory cytokine, Anti-inflammatory cytokine
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå